2010
DOI: 10.1182/blood-2009-12-259267
|View full text |Cite
|
Sign up to set email alerts
|

Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

6
160
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 164 publications
(166 citation statements)
references
References 46 publications
6
160
0
Order By: Relevance
“…The lack of effect of deletion of myeloid TF in ALI is an unexpected finding, and provides new insight into the regulation of local coagulation in the airspace. It is well established that alveolar macrophages express TF (8)(9)(10)18). Two studies of bleomycin-induced lung injury demonstrated strong up-regulation of TF mRNA (8) and protein expression (18) on macrophages during ALI.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The lack of effect of deletion of myeloid TF in ALI is an unexpected finding, and provides new insight into the regulation of local coagulation in the airspace. It is well established that alveolar macrophages express TF (8)(9)(10)18). Two studies of bleomycin-induced lung injury demonstrated strong up-regulation of TF mRNA (8) and protein expression (18) on macrophages during ALI.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, TF can be strongly induced on epithelial cells, macrophages, and other cell types in vitro (10)(11)(12)(13)(14)(15)(16). The cellular sources of TF that drive the protective effects of TF during direct ALI, and the mechanisms of the protective effects of TF in the airspace, are currently unknown.…”
mentioning
confidence: 99%
“…negatively charged phospholipids and of tissue factor (TF), they create a procoagulant surface on which coagulation factors can bind and be activated (Morel et al 2006). Indeed, the initial concept that TF presence is limited to a hemostatic envelope surrounding blood vessels has been challenged by the identification of 'blood borne' TF, either on circulating white blood cells or microvesicles, as a soluble protein, or possibly on stimulated endothelial cells (Pawlinski et al 2010).…”
Section: Pathophysiologymentioning
confidence: 99%
“…Importantly, the data presented here differ from observations in a mouse model of endotoxemia, where LPSinduced coagulation activation was partially attenuated by inhibition of either hematopoietic or non-hematopoietic sources of TF. 16 This difference is most likely explained by the fact that the level of coagulation activation in endotoxemic mice was much greater than in heme-treated mice, which allowed us to reveal the partial contribution of TF expressed by both cell types. 29 It has recently been proposed that in addition to cellular TF, procoagulant microparticles (MPs) may contribute to the propagation of coagulation in various pathological conditions.…”
mentioning
confidence: 99%
“…16 1H1 is a monoclonal rat anti-mouse TF antibody that competes for binding of factor VII. 21 Chimeric HTF BM /WT mice were administered anti-human TF (HTF1, 10 mg/kg), anti-mouse TF (1H1, 20 mg/kg) or control IgG (10 mg/kg) 30 min before heme.…”
Section: Administration Of Antibodiesmentioning
confidence: 99%